Top Markets
Coin of the day
Liminal BioSciences Inc. Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNL
Pozycja w akcjach #38949
Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm,... Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.
Cena akcji
$8.50
Ostatnia synchronizacja: 2023-09-26
Kapitalizacja rynkowa
$719.10K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel Liminal BioSciences Inc. (LMNL)

Kategoria

Historia ceny akcji dla Liminal BioSciences Inc. (LMNL)
Najwyższa cena zamknięcia: $8.45 dnia 2023-09-01

Najniższa cena zamknięcia: $1.69K dnia 2009-12-01
Historia cen akcji firmy Liminal BioSciences Inc. od 2009 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 112.62%
2022 -61.46%
2021 -76.57%
2020 -35.75%
2019 -97.45%
2018 -73.89%
2017 -28.49%
2016 -38.09%
2015 36.88%
2014 102.93%
2013 334.33%
2012 40.83%
2011 23.59%
2010 -34.41%
2009 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$506.54 29.78%
US
$843.80 29.33%
NL
$729.87 6.86%
CH
$1.07K -6.40%
KR
$252.41 11.51%
BE